Verastem (VSTM) Competitor Comparison
We are evaluating the key criteria listed to compare Verastem (VSTM) against its competitors in the Biotechnology industry.
Market Capitalization
192 / 368Gross Profits
115 / 278Total Revenue
289 / 300EBITDA
174 / 337Free Cashflow
210 / 352Quick Ratio
134 / 357Earnings per Share
270 / 359Dividend yield
0 / 6Total Cash
178 / 358Performance 3 years
288 / 368Performance 5 years
211 / 368Performance 10 years
302 / 368Linearity 3 years
263 / 368Linearity 5 years
78 / 368Linearity 10 years
249 / 368Total Rank
364 / 368Dividend Rank
300 / 368Valuation Rank
241 / 368Piotroski Rank
317 / 368Muliplier Rank
227 / 368Valuation Rank - VSTM ranking 241 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.